Maxor Announces Rebranding Of Maxor Specialty Pharmacy
AMARILLO, Texas, May 1, 2020 /PRNewswire/ — Maxor National Pharmacy Services (Maxor) today introduced the new name of its Specialty business unit, Maxor […]
MaxorPlus COVID-19 Updates Part II Webinar Available
On this April 30, 2020 webinar, Maxor’s Clinical team examines the data uncovered during month of April including testing and
Maxor COVID-19 Update #3
We are pleased to bring you another update on the COVID-19 pandemic and Maxor’s response. Despite the abrupt disruption to normal
MaxorPlus COVID-19 Webinar Available
On this April 2, 2020 webinar, Maxor’s Clinical team reviews the latest COVID-19 data and related drug pipeline trends and
Maxor COVID-19 Update #2
As the COVID-19 crisis continues to unfold, we know it is important to keep you updated on our response, perspective,
Maxor Pharmacies COVID-19 Update #1
While these are unprecedented times in many ways – in adversity we find our strength. Over the last few weeks
Maxor COVID-19 Update #1
This is the first communication of a regular publication that Maxor will release related to our Corona virus (COVID-19) perspective
Maxor’s Response to the Coronavirus
This memo details Maxor’s perspective on the current COVID-19 situation and contingency planning across Maxor’s various business lines, including PBM,
Industry News, Maxor Specialty, Press Releases
Neurelis announces commercial availability of Valtoco® (Diazepam nasal spray) for seizure cluster rescue
Chuck DeWildt, Chief Commercial Officer at Neurelis, announced Maxor Specialty Pharmacy has been selected as the national pharmacy provider and
Industry News, Maxor Specialty, Press Releases
Acentrus Specialty Partners with Maxor National Pharmacy Services to Provide Specialty Pharmacy Medications
IRVING, Texas–(BUSINESS WIRE)–Acentrus Specialty™, an Integrated Care Network and health system solution for specialty pharmacy, and Maxor National Pharmacy Services